Robert Neil Goldstone, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rectal Neoplasms | 15 | 2024 | 1152 | 1.970 |
Why?
|
Colectomy | 8 | 2024 | 692 | 1.940 |
Why?
|
Colonic Neoplasms | 10 | 2024 | 2523 | 1.230 |
Why?
|
Anus Neoplasms | 3 | 2017 | 329 | 1.160 |
Why?
|
Laparoscopy | 8 | 2024 | 2147 | 1.160 |
Why?
|
Tunica Intima | 2 | 2018 | 459 | 0.970 |
Why?
|
Ileostomy | 1 | 2024 | 120 | 0.880 |
Why?
|
Colorectal Neoplasms | 10 | 2024 | 6852 | 0.870 |
Why?
|
Colitis, Ulcerative | 4 | 2023 | 1919 | 0.770 |
Why?
|
Intestinal Perforation | 2 | 2021 | 249 | 0.750 |
Why?
|
Diverticulitis, Colonic | 2 | 2021 | 138 | 0.740 |
Why?
|
Photochemotherapy | 2 | 2018 | 820 | 0.720 |
Why?
|
HIV Seropositivity | 2 | 2017 | 960 | 0.660 |
Why?
|
Appendiceal Neoplasms | 1 | 2021 | 155 | 0.640 |
Why?
|
Carcinoma in Situ | 2 | 2016 | 796 | 0.620 |
Why?
|
Lymph Node Excision | 1 | 2024 | 1303 | 0.600 |
Why?
|
Precancerous Conditions | 4 | 2017 | 977 | 0.570 |
Why?
|
Colorectal Surgery | 1 | 2019 | 122 | 0.560 |
Why?
|
Anal Canal | 2 | 2017 | 372 | 0.550 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2023 | 2420 | 0.550 |
Why?
|
Photosensitizing Agents | 2 | 2018 | 618 | 0.540 |
Why?
|
Hyperplasia | 3 | 2018 | 1154 | 0.530 |
Why?
|
Intestinal Obstruction | 1 | 2019 | 433 | 0.510 |
Why?
|
Arteriovenous Fistula | 1 | 2018 | 313 | 0.470 |
Why?
|
Neoplasm Recurrence, Local | 8 | 2024 | 9273 | 0.470 |
Why?
|
Colitis | 1 | 2023 | 1229 | 0.470 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2018 | 292 | 0.470 |
Why?
|
Catheter Ablation | 2 | 2017 | 2740 | 0.450 |
Why?
|
Neoadjuvant Therapy | 7 | 2023 | 2821 | 0.440 |
Why?
|
Postoperative Complications | 10 | 2024 | 15637 | 0.430 |
Why?
|
Income | 1 | 2021 | 1872 | 0.410 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2019 | 1110 | 0.400 |
Why?
|
Light Coagulation | 1 | 2011 | 71 | 0.390 |
Why?
|
Abdominal Abscess | 2 | 2022 | 152 | 0.370 |
Why?
|
HIV Seronegativity | 1 | 2011 | 211 | 0.360 |
Why?
|
Corneal Wavefront Aberration | 1 | 2010 | 7 | 0.360 |
Why?
|
Health Expenditures | 2 | 2022 | 2347 | 0.350 |
Why?
|
Infrared Rays | 1 | 2011 | 245 | 0.350 |
Why?
|
Homosexuality, Male | 3 | 2017 | 1329 | 0.340 |
Why?
|
Lasers, Excimer | 1 | 2010 | 69 | 0.340 |
Why?
|
Stromal Cells | 1 | 2015 | 1326 | 0.340 |
Why?
|
Adenocarcinoma | 6 | 2022 | 6313 | 0.320 |
Why?
|
Keratomileusis, Laser In Situ | 1 | 2010 | 84 | 0.320 |
Why?
|
Retrospective Studies | 30 | 2024 | 80168 | 0.320 |
Why?
|
Contact Lenses | 1 | 2010 | 138 | 0.310 |
Why?
|
Myopia | 1 | 2010 | 245 | 0.290 |
Why?
|
Anastomosis, Surgical | 3 | 2021 | 983 | 0.290 |
Why?
|
General Surgery | 1 | 2019 | 1677 | 0.290 |
Why?
|
Colonic Polyps | 1 | 2011 | 551 | 0.270 |
Why?
|
Colon | 3 | 2020 | 1787 | 0.270 |
Why?
|
Colonoscopy | 3 | 2022 | 1388 | 0.250 |
Why?
|
Appendicitis | 2 | 2022 | 674 | 0.250 |
Why?
|
Neoplasm Staging | 11 | 2023 | 11152 | 0.250 |
Why?
|
Colostomy | 1 | 2024 | 105 | 0.230 |
Why?
|
Medicare | 1 | 2022 | 6741 | 0.230 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2017 | 4023 | 0.220 |
Why?
|
Matched-Pair Analysis | 1 | 2023 | 283 | 0.210 |
Why?
|
Emergencies | 2 | 2019 | 1209 | 0.210 |
Why?
|
Hypoalbuminemia | 1 | 2023 | 87 | 0.200 |
Why?
|
Treatment Outcome | 13 | 2024 | 64378 | 0.200 |
Why?
|
Aged | 19 | 2024 | 168218 | 0.200 |
Why?
|
Kaplan-Meier Estimate | 5 | 2020 | 6493 | 0.200 |
Why?
|
Humans | 52 | 2024 | 758406 | 0.190 |
Why?
|
Colon, Transverse | 1 | 2021 | 24 | 0.190 |
Why?
|
Middle Aged | 22 | 2024 | 219568 | 0.180 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2021 | 83 | 0.180 |
Why?
|
Hospitals, Community | 1 | 2023 | 367 | 0.180 |
Why?
|
Hospices | 1 | 2023 | 245 | 0.180 |
Why?
|
Anastomotic Leak | 1 | 2021 | 163 | 0.170 |
Why?
|
Japan | 1 | 2024 | 1366 | 0.170 |
Why?
|
New York | 2 | 2020 | 874 | 0.170 |
Why?
|
Male | 26 | 2024 | 358747 | 0.160 |
Why?
|
Abdomen, Acute | 1 | 2019 | 122 | 0.160 |
Why?
|
Rectum | 2 | 2023 | 895 | 0.160 |
Why?
|
Cultural Competency | 1 | 2022 | 297 | 0.160 |
Why?
|
Diverticulitis | 1 | 2021 | 182 | 0.150 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2021 | 3527 | 0.150 |
Why?
|
Proctoscopy | 1 | 2017 | 40 | 0.150 |
Why?
|
Hospital Mortality | 2 | 2024 | 5272 | 0.150 |
Why?
|
Treatment Refusal | 1 | 2020 | 429 | 0.140 |
Why?
|
Disease-Free Survival | 5 | 2022 | 6821 | 0.140 |
Why?
|
Survival Rate | 4 | 2024 | 12721 | 0.140 |
Why?
|
Hospice Care | 1 | 2023 | 677 | 0.140 |
Why?
|
Disease Progression | 2 | 2024 | 13468 | 0.130 |
Why?
|
Metformin | 1 | 2023 | 907 | 0.130 |
Why?
|
Rose Bengal | 1 | 2016 | 115 | 0.130 |
Why?
|
Prognosis | 8 | 2022 | 29557 | 0.130 |
Why?
|
Neoplasms, Second Primary | 1 | 2023 | 1056 | 0.130 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2016 | 283 | 0.130 |
Why?
|
Female | 22 | 2024 | 390323 | 0.120 |
Why?
|
Digestive System Surgical Procedures | 1 | 2020 | 575 | 0.120 |
Why?
|
Sus scrofa | 1 | 2016 | 428 | 0.120 |
Why?
|
Emigrants and Immigrants | 1 | 2021 | 539 | 0.120 |
Why?
|
Vascular Grafting | 1 | 2016 | 152 | 0.120 |
Why?
|
Adult | 15 | 2024 | 219935 | 0.120 |
Why?
|
Elasticity | 1 | 2016 | 652 | 0.120 |
Why?
|
United States | 10 | 2024 | 72136 | 0.110 |
Why?
|
Reoperation | 1 | 2024 | 4282 | 0.110 |
Why?
|
Robotics | 1 | 2021 | 874 | 0.110 |
Why?
|
Anemia | 1 | 2023 | 1504 | 0.110 |
Why?
|
Saphenous Vein | 1 | 2016 | 517 | 0.110 |
Why?
|
Intestines | 1 | 2022 | 1906 | 0.110 |
Why?
|
Carotid Arteries | 1 | 2016 | 939 | 0.100 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1931 | 0.100 |
Why?
|
Papillomavirus Infections | 2 | 2017 | 1612 | 0.100 |
Why?
|
Demography | 1 | 2016 | 1651 | 0.100 |
Why?
|
Terminal Care | 1 | 2023 | 1750 | 0.100 |
Why?
|
Aged, 80 and over | 5 | 2024 | 58683 | 0.090 |
Why?
|
Swine | 2 | 2022 | 5892 | 0.090 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12096 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3142 | 0.090 |
Why?
|
Proportional Hazards Models | 3 | 2022 | 12440 | 0.090 |
Why?
|
Patient Readmission | 1 | 2024 | 3261 | 0.090 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39059 | 0.080 |
Why?
|
Refraction, Ocular | 1 | 2010 | 179 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2021 | 1831 | 0.080 |
Why?
|
Neoplasm Invasiveness | 3 | 2022 | 3617 | 0.080 |
Why?
|
Appendectomy | 2 | 2022 | 431 | 0.080 |
Why?
|
Quality Improvement | 1 | 2024 | 3806 | 0.080 |
Why?
|
Age Factors | 2 | 2022 | 18358 | 0.080 |
Why?
|
Bariatric Surgery | 1 | 2018 | 986 | 0.080 |
Why?
|
Length of Stay | 4 | 2024 | 6439 | 0.080 |
Why?
|
Patient Care Team | 1 | 2019 | 2504 | 0.080 |
Why?
|
Developing Countries | 1 | 2021 | 2866 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7225 | 0.080 |
Why?
|
Abscess | 2 | 2022 | 605 | 0.070 |
Why?
|
Obesity, Morbid | 1 | 2018 | 1277 | 0.070 |
Why?
|
Risk Factors | 5 | 2023 | 73809 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3211 | 0.070 |
Why?
|
Immunohistochemistry | 2 | 2022 | 11070 | 0.070 |
Why?
|
Crohn Disease | 1 | 2019 | 2275 | 0.070 |
Why?
|
Rats, Sprague-Dawley | 1 | 2018 | 8143 | 0.070 |
Why?
|
Young Adult | 5 | 2021 | 58808 | 0.070 |
Why?
|
Pain, Postoperative | 1 | 2016 | 1721 | 0.070 |
Why?
|
Graft Survival | 1 | 2016 | 3794 | 0.060 |
Why?
|
Alphapapillomavirus | 1 | 2008 | 219 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2022 | 7378 | 0.060 |
Why?
|
Mass Screening | 1 | 2021 | 5427 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3425 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 1 | 2015 | 1634 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3364 | 0.060 |
Why?
|
Pilot Projects | 1 | 2017 | 8553 | 0.060 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10171 | 0.060 |
Why?
|
Logistic Models | 1 | 2019 | 13276 | 0.060 |
Why?
|
Abdomen | 1 | 2009 | 1129 | 0.060 |
Why?
|
Prospective Studies | 4 | 2024 | 54137 | 0.060 |
Why?
|
Adipose Tissue | 1 | 2015 | 3299 | 0.050 |
Why?
|
Stem Cells | 1 | 2015 | 3521 | 0.050 |
Why?
|
Risk Assessment | 2 | 2023 | 23884 | 0.050 |
Why?
|
Cause of Death | 2 | 2024 | 3675 | 0.050 |
Why?
|
Internship and Residency | 1 | 2022 | 5865 | 0.050 |
Why?
|
Rats | 1 | 2018 | 23679 | 0.050 |
Why?
|
Adolescent | 5 | 2021 | 87892 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2015 | 2882 | 0.050 |
Why?
|
Visual Acuity | 1 | 2010 | 2642 | 0.040 |
Why?
|
Inpatients | 2 | 2023 | 2551 | 0.040 |
Why?
|
Colon, Sigmoid | 1 | 2020 | 124 | 0.040 |
Why?
|
Time Factors | 2 | 2011 | 39872 | 0.040 |
Why?
|
RNA, Viral | 1 | 2008 | 2836 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2015 | 18940 | 0.040 |
Why?
|
Liver Cirrhosis | 1 | 2009 | 1930 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18119 | 0.040 |
Why?
|
Emigration and Immigration | 1 | 2021 | 394 | 0.040 |
Why?
|
Developed Countries | 1 | 2021 | 440 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2015 | 11471 | 0.040 |
Why?
|
Causality | 1 | 2024 | 1241 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13245 | 0.040 |
Why?
|
Animals | 3 | 2022 | 167768 | 0.040 |
Why?
|
SEER Program | 1 | 2021 | 1530 | 0.030 |
Why?
|
Nursing Homes | 1 | 2023 | 1080 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2021 | 1557 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1611 | 0.030 |
Why?
|
World Health Organization | 1 | 2021 | 1312 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 7980 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 21017 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 2943 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 22032 | 0.030 |
Why?
|
Endoscopy | 1 | 2022 | 1834 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2023 | 15225 | 0.020 |
Why?
|
Cost of Illness | 1 | 2021 | 1936 | 0.020 |
Why?
|
Overweight | 1 | 2021 | 2411 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3840 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 41256 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8530 | 0.020 |
Why?
|
Curriculum | 1 | 2022 | 3717 | 0.020 |
Why?
|
Computer Simulation | 1 | 2022 | 6201 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2019 | 3485 | 0.020 |
Why?
|
Comorbidity | 1 | 2022 | 10495 | 0.020 |
Why?
|
Registries | 1 | 2024 | 8175 | 0.020 |
Why?
|
Genotype | 1 | 2022 | 12945 | 0.020 |
Why?
|
Serum Albumin | 1 | 2009 | 673 | 0.020 |
Why?
|
Clinical Competence | 1 | 2022 | 4775 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 21272 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2023 | 22029 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5331 | 0.010 |
Why?
|
Diet | 1 | 2021 | 8005 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6068 | 0.010 |
Why?
|
Biopsy | 1 | 2008 | 6768 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14641 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12951 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15785 | 0.010 |
Why?
|
Prevalence | 1 | 2008 | 15651 | 0.010 |
Why?
|
Child | 1 | 2018 | 79818 | 0.010 |
Why?
|